Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2425)
All Articles published online
|
Publishing Process of This Article
|
May 15, 2023 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Qu FJ, Wu S, Kong Y. Oral fruquintinib combined with tegafur-gimeracil-oteracil potassium for advanced colorectal cancer to obtain longer progression-free survival: A case report. World J Gastrointest Oncol 2023; 15(5): 902-910 [PMID: 37275454 DOI: 10.4251/wjgo.v15.i5.902] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v15/i5/902.htm |
| Number | Citing Articles |
| 1 |
D. Xu, S. Zeng, W. Qiu, G. Wang, Z. Qin, Y. Liu, S. Zhou, Z. Zhang, W. Chang, Q. Feng, J. Xu. Fruquintinib in refractory metastatic colorectal cancer: a multicenter real-world study. ESMO Open 2024; 9(11): 103702 doi: 10.1016/j.esmoop.2024.103702
|
| 2 |
|